Results 201 to 210 of about 1,920,751 (260)

Central Nervous System Metastases

Hematology/Oncology Clinics of North America, 2022
The proportion of patients developing central nervous system (CNS) metastasis is increasing. Most are identified once symptomatic. Surgical resection is indicated for solitary or symptomatic brain metastases, separation surgery for compressive radioresistant spinal metastases, and instrumentation for unstable spinal lesions.
Edwin, Nieblas-Bedolla, Jeffrey, Zuccato, Harriet, Kluger, Gelareh, Zadeh, Priscilla K, Brastianos   +4 more
openaire   +2 more sources

Central nervous system regeneration

Cell, 2022
Neurons of the mammalian central nervous system fail to regenerate. Substantial progress has been made toward identifying the cellular and molecular mechanisms that underlie regenerative failure and how altering those pathways can promote cell survival and/or axon regeneration.
Supraja G. Varadarajan, John L. Hunyara, Natalie R. Hamilton, Alex L. Kolodkin, Andrew D. Huberman   +4 more
openaire   +2 more sources

Central nervous system

Cancer Biomarkers, 2011
Several different types of tumors, benign and malignant, have been identified in the central nervous system (CNS). The prognoses for these tumors are related to several factors, such as the age of the patient and the location and histology of the tumor.
D Cory, Adamson, B Ahmed K, Rasheed, Roger E, McLendon, Darell D, Bigner   +3 more
openaire   +2 more sources

Central nervous system leukemia

Current Opinion in ONCOLOGY, 1996
The treatment of central nervous system (CNS) leukemia still poses a significant challenge to the clinical oncologist despite significant advances in therapeutic strategies that are directly targeted at the CNS. This article reviews the evolving definition of CNS leukemia, the current status of therapy for the prevention and treatment of overt CNS ...
S M, Blaney, D G, Poplack
openaire   +2 more sources